Literature DB >> 20452224

New potent inhibitors of tyrosinase: novel clues to binding of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides to the dicopper active site.

Usman Ghani1, Nisar Ullah.   

Abstract

A series of 1,3,4-thiadiazole-2(3H)-thiones, 1,3,4-oxadiazole-2(3H)-thiones, 4-amino-1,2,4-triazole-5(4H)-thiones, and substituted hydrazides were tailored and synthesized as new potent inhibitors of tyrosinase. The rationale for inhibitor design was based on the active site structural evidence from the crystal structures of bacterial tyrosinase and potato catechol oxidase enzymes. Kinetic and active site binding studies suggested mono-dentate binding of thiadiazole, oxadiazole, and triazole rings to the active site dicopper center of tyrosinase including hydrophobicity contributing to the potent inhibition. Kinetic plots showed mixed-type of inhibition by all 25 compounds. Substitutions at C3 of the triazole ring and C5 of the thiadiazole/oxadiazole rings were found to be playing a major role in the high binding affinity to tyrosinase. The current work may help develop new potent tyrosinase inhibitors against hyperpigmentation including potential insecticides.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20452224     DOI: 10.1016/j.bmc.2010.04.021

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  9 in total

1.  AMP-activated protein kinase selectively inhibited by the type II inhibitor SBI-0206965.

Authors:  Toby A Dite; Christopher G Langendorf; Ashfaqul Hoque; Sandra Galic; Richard J Rebello; Ashley J Ovens; Lisa M Lindqvist; Kevin R W Ngoei; Naomi X Y Ling; Luc Furic; Bruce E Kemp; John W Scott; Jonathan S Oakhill
Journal:  J Biol Chem       Date:  2018-04-25       Impact factor: 5.157

2.  Existence of G-quadruplex structures in promoter region of oncogenes confirmed by G-quadruplex DNA cross-linking strategy.

Authors:  Libo Yuan; Tian Tian; Yuqi Chen; Shengyong Yan; Xiwen Xing; Zhengan Zhang; Qianqian Zhai; Liang Xu; Shaoru Wang; Xiaocheng Weng; Bifeng Yuan; Yuqi Feng; Xiang Zhou
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

3.  Discovery of highly potent tyrosinase inhibitor, T1, with significant anti-melanogenesis ability by zebrafish in vivo assay and computational molecular modeling.

Authors:  Wang-Chuan Chen; Tien-Sheng Tseng; Nai-Wan Hsiao; Yun-Lian Lin; Zhi-Hong Wen; Chin-Chuan Tsai; Yu-Ching Lee; Hui-Hsiung Lin; Keng-Chang Tsai
Journal:  Sci Rep       Date:  2015-01-23       Impact factor: 4.379

4.  Synthesis of chiral pyrazolo[4,3-e][1,2,4]triazine sulfonamides with tyrosinase and urease inhibitory activity.

Authors:  Mariusz Mojzych; Paweł Tarasiuk; Katarzyna Kotwica-Mojzych; Muhammad Rafiq; Sung-Yum Seo; Michał Nicewicz; Emilia Fornal
Journal:  J Enzyme Inhib Med Chem       Date:  2016-10-25       Impact factor: 5.051

5.  Novel 1,2,4-triazole analogues as mushroom tyrosinase inhibitors: synthesis, kinetic mechanism, cytotoxicity and computational studies.

Authors:  Balasaheb D Vanjare; Prasad G Mahajan; Nilam C Dige; Hussain Raza; Mubashir Hassan; Yohan Han; Song Ja Kim; Sung-Yum Seo; Ki Hwan Lee
Journal:  Mol Divers       Date:  2020-05-12       Impact factor: 2.943

6.  Repositioning of Thiourea-Containing Drugs as Tyrosinase Inhibitors.

Authors:  Joonhyeok Choi; Jun-Goo Jee
Journal:  Int J Mol Sci       Date:  2015-12-02       Impact factor: 5.923

7.  Synthesis of novel compounds as new potent tyrosinase inhibitors.

Authors:  Hooshang Hamidian
Journal:  Biomed Res Int       Date:  2013-10-22       Impact factor: 3.411

8.  3-Benzhydryl-1,3,4-thia-diazole-2(3H)-thione.

Authors:  Megan T Thornton; Peter C Healy; Luke C Henderson
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-08-10

9.  Theoretical Studies of Cyanophycin Dipeptides as Inhibitors of Tyrosinases.

Authors:  Agnieszka Krzemińska; Natalia Kwiatos; Franciela Arenhart Soares; Alexander Steinbüchel
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.